Health

Keeping Up with Advancements in Cell and Gene Therapies, Upcoming Webinar Hosted by Xtalks and Worldwide Clinical Trials

Leave a comment


The few approved advanced therapies and the many programs which have gone through development offer valuable insight for use in directing future programs.


TORONTO (PRWEB)

Monogenic diseases have found much promise in the clinical development of cell and gene therapies. In recent years, these therapeutics have advanced to utilize more successful vectors, and many patients are seeing cell or gene therapy treatments for their disease entering into clinical trials. The few approved advanced therapies and the many programs which have gone through development offer valuable insight for use in directing future programs.

Our speakers will cover the latest trends and challenges in development of these advanced therapeutics, as well as how the pandemic has challenged their advancement. Topics will include how to navigate clinical holds, site activation trends and challenges, strategies for patient competition, and specifics on rare disease cell and gene therapies.

Register for this webinar, sponsored by Worldwide Clinical Trials, for an update on the current trends and challenges cell and gene therapy development programs face.

Join Chris Jenkins, PHD, MPH, RBP, CHMM, Principal Partner & Chief Gene Therapy Biosafety Officer, CBS; and experts from Worldwide Clinical Trials, Dana Durst, Senior Director, Site Activation and Regulatory Therapeutic Lead, Oncology; Derek Ansel, MS, CCRA, Senior Director, Therapeutic Strategy Lead, Rare Diseases; and Cathy Purvis, MBA, Site Activation Manager, for the live webinar on Wednesday, May 25, 2022, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Changing Times, Changing Therapies: Keeping Up with Advancements in Cell and Gene Therapies.

ABOUT WORLDWIDE CLINICAL TRIALS

Worldwide Clinical Trials is a global, midsize contract research organization (CRO) that provides top-performing preclinical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries.

Founded in 1986 by physicians committed to advancing medical science, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include cardiovascular, metabolic, neuroscience, oncology, and rare diseases. Operating in 60+ countries with offices in North and South America, Eastern and Western Europe, Russia, and Asia, Worldwide is powered by its more than 2,800 employee experts.

For more information, please visit http://www.worldwide.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Leave a Reply